NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT and 10% CONVERTIBLE, SECURED PROMISSORY NOTELoan Agreement • October 28th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
Amendment No. 1 To Amended and Restated Recapitalization AgreementRecapitalization Agreement • October 28th, 2004 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Delaware
This Amendment No. 1 To Amended and Restated Recapitalization Agreement (this “Amendment”) is made and entered into as of October 22, 2004 (the “Amendment Date”) by and between Northwest Biotherapeutics, Inc., and its affiliates, if any (collectively, the “Company”), a Delaware corporation with offices at 22322 20th Ave SE, Suite 150, Bothell, Washington, 98021, and Toucan Capital Fund II, L.P., and its designees (collectively, “Investor”), a Delaware limited partnership with offices at 7600 Wisconsin Avenue, Bethesda, MD 20814. All capitalized terms used herein but not otherwise defined shall have the meaning given such terms in the Agreement (as defined below).
